Alexander-Miller et al., “Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy” PNAS USA 93(9):4102-4107 (1996). |
Bloom et al., “Identification of tyrosine-related protein 2 as a tumor rejection antigen for the B16 melanoma” J. Exp. Med. 185(3):453 (1997). |
Borchardt et al., “Small molecule-dependent genetic selection in stochastic nanodroplets as a means of detecting protein-ligand interactions on a large scale” Chem. Biol. 4(12):961-968 (1997). |
Bouchard et al., “Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells” Eur. J. Biochem. 219(1-2):127-134 (1994). |
Colaco, “Why are dendritic cells central to cancer immunotherapy?” Mol. Med. Today:14-17 (Jan. 1999). |
Gish et al., “Identification of protein coding regions by database similarity search” Nature Genetics 3:266-273 (1993). |
Kawakami et al., “Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor” PNAS USA 91(9):3515-3519 (1994). |
Kawakami et al., “Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection” PNAS USA 91:6458-6462 (1994). |
Lindauer et al., “The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes” J. Mol. Med. 76:32-47 (1998). |
Pardoll, “Cancer vaccines” Nature Med. Vaccine Supp. 4(5):525-531 (May 1998). |
Rosenberg et al., “Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma” Nature Med. 4(3):321-327 (1998). |
Salgaller et al. “Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides” Cancer Res. 55:4972-4979 (1995). |
Schena et al., “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes” PNAS USA 93:10614-10619 (1996). |
Shepherd et al., “Preparation and screening of an arrayed human genomic library generated with the P1 cloning system” PNAS USA 91:2629-2633 (1994). |
Tam, “Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system” PNAS USA 85:5409-5413 (1998). |
Türeci et al., “Serological analysis of human tumor antigens: Molecular definition and implications” Mol. Med. Today 3(8):342-349 (Aug. 1997). |
Zhai et al., “Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100” J. Immunol. 20(1):15-25 (1997). |
Zügel et al., “Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogoues” J. Immunol. 161:1705-1709 (1998). |